Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy

被引：15

作者：

Korenblik, R. ^{[1
,2
]}

Olij, B. ^{[1
,2
]}

Aldrighetti, L. A. ^{[10
]}

Abu Hilal, M. ^{[11
]}

Ahle, M. ^{[12
]}

Arslan, B. ^{[8
]}

van Baardewijk, L. J. ^{[13
]}

Baclija, I ^{[14
]}

Bent, C. ^{[15
,16
]}

Bertrand, C. L. ^{[17
]}

Bjornsson, B. ^{[18
]}

de Boer, M. T. ^{[19
]}

de Boer, S. W. ^{[3
]}

Bokkers, R. P. H. ^{[20
]}

Rinkes, I. H. M. Borel ^{[21
]}

Breitenstein, S. ^{[6
]}

Bruijnen, R. C. G. ^{[22
]}

Bruners, P. ^{[5
]}

Camacho, J. C. ^{[24
]}

Cappelli, A. ^{[25
]}

Carling, U. ^{[26
]}

Chan, B. K. Y. ^{[27
]}

Chang, D. H. ^{[28
]}

Choi, J. ^{[29
]}

Codina Font, J. ^{[30
]}

Crawford, M. ^{[31
]}

Croagh, D. ^{[32
]}

Cugat, E. ^{[33
]}

Davis, R. ^{[34
]}

De Boo, D. W. ^{[35
]}

De Cobelli, F. ^{[36
]}

De Wispelaere, J. F. ^{[37
]}

van Delden, O. M. ^{[38
]}

Delle, M. ^{[39
]}

Detry, O. ^{[40
]}

Dili, A. ^{[17
]}

Erdmann, J., I ^{[41
]}

Fisher, O. ^{[31
]}

Fondevila, C. ^{[42
]}

Fretland, A. ^{[43
]}

Garcia Borobia, F. ^{[44
]}

Gelabert, A. ^{[45
,46
]}

Gerard, L. ^{[47
]}

Giuliante, F. ^{[48
]}

Gobardhan, P. D. ^{[49
]}

Gomez, F. ^{[50
]}

Grunberger, T. ^{[51
]}

Grunhagen, D. J. ^{[52
]}

Guitart, J. ^{[46
]}

Hagendoorn, J. ^{[21
]}

机构：

[1] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht Univ Singel 40, NL-6229 ET Maastricht, Netherlands

[2] Maastricht Univ Med Ctr, Dept Surg, Maastricht, Netherlands

[3] Maastricht Univ Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands

[4] Univ Hosp Aachen, Dept Gen Visceral & Transplant Surg, Aachen, Germany

[5] Univ Hosp Aachen, Dept Radiol, Aachen, Germany

[6] Cantonal Hosp Winterthur, Dept Gen & Visceral Surg, Winterthur, Switzerland

[7] Cantonal Hosp Winterthur, Dept Radiol, Winterthur, Switzerland

[8] Rush Univ Med Ctr, Dept Radiol, Chicago, IL USA

[9] Rush Univ Med Ctr Chicago, Dept Surg, Chicago, IL USA

[10] Osped San Raffaele, Dept Surg, Milan, Italy

[11] Fdn Poliambulanza, Dept Surg, Brescia, Italy

[12] Univ Hosp, Dept Radiol, Linkoping, Sweden

[13] Maxima Med Ctr, Dept Radiol, Eindhoven, Netherlands

[14] Clin Favoriten, Dept Radiol, Vienna, Austria

[15] Royal Bournemouth & Christchurch Hosp, Dept Radiol, Bournemouth, Dorset, England

[16] Royal Bournemouth & Christchurch Hosp, Dept Radiol, christuchurch, England

[17] CHU UCLouvain Namur, Dept Surg, Namur, Belgium

[18] Linkoping Univ Hosp, Dept Surg Biomed & Clin Sci, Linkoping, Sweden

[19] Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands

[20] Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands

[21] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands

[22] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands

[23] Univ Hosp Heidelberg, Dept Surg, Heidelberg, Germany

[24] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA

[25] St Orsola Malpighi Hosp, Dept Radiol, IRCCS Azienda Osped Univ Bologna, Bologna, Italy

[26] Univ Hosp Oslo, Dept Radiol, Oslo, Norway

[27] Aintree Univ Hosp NHS Fdn Trust, Dept Surg, Liverpool, Merseyside, England

[28] Univ Hosp Heidelberg, Dept Radiol, Heidelberg, Germany

[29] Western Hlth Footscray, Dept Surg, Footscray, Vic, Australia

[30] Univ Hosp Dr Josep Trueta Girona, Dept Radiol, Girona, Spain

[31] Royal Prince Alfred Hosp, Dept Surg, Camperdown, NSW, Australia

[32] Monash Hlth, Dept Surg, Clayton, Vic, Australia

[33] Univ Hosp Germans Trias I Pujol, Dept Surg, Badalona, Spain

[34] Aintree Univ Hosp NHS Fdn Trust, Dept Radiol, Liverpool, Merseyside, England

[35] Monash Hlth, Dept Radiol, Clayton, Vic, Australia

[36] Osped San Raffaele, Dept Radiol, Milan, Italy

[37] CHU UCLouvain Namur, Dept Radiol, Namur, Belgium

[38] Amsterdam Univ Med Ctr Locat AMC, Dept Radiol, Amsterdam, Netherlands

[39] Karolinska Univ Hosp, Dept Radiol, Stockholm, Sweden

[40] CHU Liege, Dept Surg, Liege, Belgium

[41] Amsterdam Univ Med Ctr Locat AMC, Dept Surg, Amsterdam, Netherlands

[42] Hosp Clin Barcelona, Dept Surg, Barcelona, Spain

[43] Univ Hosp Oslo, Dept Surg, Oslo, Norway

[44] Hosp Parc Tauli Sabadell, Dept Surg, Sabadell, Spain

[45] Hosp Parc Tauli Sabadell, Dept Radiol, Sabadell, Spain

[46] Univ Hosp Mutua Terassa, Dept Radiol, Terassa, Spain

[47] CHU Liege, Dept Radiol, Liege, Belgium

[48] Gemelli Univ Hosp Rome, Dept Surg, Rome, Italy

[49] Amphia, Dept Surg, Breda, Netherlands

[50] Hosp Clin Barcelona, Dept Radiol, Barcelona, Spain

来源：

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY | 2022年 / 45卷 / 09期

关键词：

Colorectal cancer liver metastases (CRLM); Portal vein embolization (PVE); Hepatic vein embolization (HVE); Combined portal- and hepatic vein embolization (PVE; HVE); Liver hypertrophy; Future liver remnant (FLR); HEPATOBILIARY SCINTIGRAPHY; 2-STAGE HEPATECTOMY; VENOUS DEPRIVATION; COMPLETE RESECTION; MAJOR HEPATECTOMY; MULTIPLE;

D O I：

10.1007/s00270-022-03176-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Study Purpose The DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients with borderline resectable colorectal cancer liver metastases. Methods The DRAGON 1 trial is a worldwide multicenter prospective single arm trial. The primary endpoint is a composite of the safety of PVE/HVE, 90-day mortality, and one year accrual monitoring of each participating center. Secondary endpoints include: feasibility of resection, the used PVE and HVE techniques, FLR-hypertrophy, liver function (subset of centers), overall survival, and disease-free survival. All complications after the PVE/HVE procedure are documented. Liver volumes will be measured at week 1 and if applicable at week 3 and 6 after PVE/HVE and follow-up visits will be held at 1, 3, 6, and 12 months after the resection. Results Not applicable. Conclusion DRAGON 1 is a prospective trial to assess the safety and feasibility of PVE/HVE. Participating study centers will be trained, and procedures standardized using Work Instructions (WI) to prepare for the DRAGON 2 randomized controlled trial. Outcomes should reveal the accrual potential of centers, safety profile of combined PVE/HVE and the effect of FLR-hypertrophy induction by PVE/HVE in patients with CRLM and a small FLR.

引用

页码：1391 / 1398

页数：8

共 25 条

[1] Complete response of colorectal liver metastases after chemotherapy:: Does it mean cure?
Benoist, Stephane
Brouquet, Antoine
Penna, Christophe
Julie, Catherine
El Hajjam, Mostafa
Chagnon, Sophie
Mitry, Emmanuel
Rougier, Philippe
Nordlinger, Bernard
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3939 - 3945
[2] High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome
Brouquet, Antoine
Abdalla, Eddie K.
Kopetz, Scott
Garrett, Christopher R.
Overman, Michael J.
Eng, Cathy
Andreou, Andreas
Loyer, Evelyne M.
Madoff, David C.
Curley, Steven A.
Vauthey, Jean-Nicolas
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (08) : 1083 - 1090
[3] Assessment of Future Remnant Liver Function Using Hepatobiliary Scintigraphy in Patients Undergoing Major Liver Resection
de Graaf, Wilmar
van Lienden, Krijn P.
Dinant, Sander
Roelofs, Joris J. T. H.
Busch, Olivier R. C.
Gouma, Dirk J.
Bennink, Roelof J.
van Gulik, Thomas M.
[J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (02) : 369 - 378
[4] Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry
Dinant, Sander
de Graaf, Wilmar
Verwer, Bart J.
Bennink, Roelof J.
van Lienden, Krijn P.
Gouma, Dirk J.
van Vliet, Arlne K.
van Gulik, Thomas M.
[J]. JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (05) : 685 - 692
[5] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
Dindo, D
Demartines, N
Clavien, PA
[J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
[6] Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function
Guiu, Boris
Quenet, Francois
Escal, Laure
Bibeau, Frederic
Piron, Lauranne
Rouanet, Philippe
Fabre, Jean-Michel
Jacquet, Eric
Denys, Alban
Kotzki, Pierre-Olivier
Verzilli, Daniel
Deshayes, Emmanuel
[J]. EUROPEAN RADIOLOGY, 2017, 27 (08) : 3343 - 3352
[7] Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique
Guiu, Boris
Chevallier, Patrick
Denys, Alban
Delhom, Elisabeth
Pierredon-Foulongne, Marie-Ange
Rouanet, Philippe
Fabre, Jean-Michel
Quenet, Francois
Herrero, Astrid
Panaro, Fabrizio
Baudin, Guillaume
Ramos, Jeanne
[J]. EUROPEAN RADIOLOGY, 2016, 26 (12) : 4259 - 4267
[8] Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis
Heil, J.
Korenblik, R.
Heid, F.
Bechstein, W. O.
Bemelmans, M.
Binkert, C.
Bjornsson, B.
Breitenstein, S.
Detry, O.
Dili, A.
Dondelinger, R. F.
Gerard, L.
Gimenez-Maurel, T.
Guiu, B.
Heise, D.
Hertl, M.
Kalil, J. A.
Klein, J. J.
Lakoma, A.
Neumann, U. P.
Olij, B.
Pappas, S. G.
Sandstrom, P.
Schnitzbauer, A.
Serrablo, A.
Tasse, J.
Van der Leij, C.
Metrakos, P.
Van Dam, R.
Schadde, E.
[J]. BRITISH JOURNAL OF SURGERY, 2021, 108 (07) : 834 - 842
[9] Preoperative Portal Vein Embolization Alone with Biliary Drainage Compared to a Combination of Simultaneous Portal Vein, Right Hepatic Vein Embolization and Biliary Drainage in Klatskin Tumor
Hocquelet, Arnaud
Sotiriadis, Charalampos
Duran, Rafael
Guiu, Boris
Yamaguchi, Takamune
Halkic, Nermin
Melloul, Emmanuel
Demartines, Nicolas
Denys, Alban
[J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (12) : 1885 - 1891
[10] A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases
Jaeck, D
Oussoultzoglou, E
Rosso, E
Greget, M
Weber, JC
Bachellier, P
[J]. ANNALS OF SURGERY, 2004, 240 (06) : 1037 - 1051

← 1 2 3 →